Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-28T14:24:27.905Z Has data issue: false hasContentIssue false

Cyproheptadine and the treatment of an unconscious patient with the serotonin syndrome

Published online by Cambridge University Press:  11 July 2005

G. D. Baigel
Affiliation:
Nuffield Department of Anaesthetics, John Radcliffe Hospital, Oxford, UK
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
© 2003 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705713.Google Scholar
Bloch M, Stager SV, Braun AR, Rubinow DR. Severe psychiatric symptoms associated with paroxetine withdrawal. Lancet 1995; 346: 57.Google Scholar
Mason BJ, Blackburn KH. Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother 1997; 31: 175177.Google Scholar
Dunbar GC. An interim overview of the safety and tolerability of paroxetine. Acta Psychiatr Scand Suppl 1989; 350: 135137.Google Scholar
Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: a randomised double-blind trial. J Clin Psychiatry 1999; 60: 107115.Google Scholar
Strayhorn JM Jr. Case study: cyproheptadine and aggression in a five-year old boy. J Am Acad Child Adolesc Psychiatry 1998; 37: 668670.Google Scholar
McFadden EP, Clarke J, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991; 324: 648654.Google Scholar